Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway

Kwang Hwan Park, Boryung Park, Dong Suk Yoon, Seung Hyun Kwon, Dong Min Shin, Jin Woo Lee, Hyun Gyu Lee, Jae Hyuck Shim, Jeon Han Park, Jae Myun Lee

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Zinc, an essential trace element, inhibits osteoclast differentiation in vitro and in vivo. The molecular mechanism for the inhibitory effect of zinc, however, is poorly understood. The purpose of this study was to investigate the effect of zinc and determine its molecular mechanism on receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis in mouse bone marrow-derived monocyte cells (BMMs) and RAW264.7 cells. Results: In BMMs, zinc treatment during osteoclast differentiation decreased RANKL-induced osteoclast formation in a dose-dependent manner. We show that zinc suppressed the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Zinc also accumulated phospho-Nfatc1 (p-Nfatc1) in the cytosol in a dose-dependent manner and inhibited the translocation of Nfatc1 to the nucleus in RAW264.7 cells. Zinc suppressed the activities of Nfatc1 in the nucleus without changing the activities of NF-κB in RAW264.7 cells. In contrast, calcineurin activity decreased in response to zinc but its protein level was unchanged. RANKL-induced Ca§ssup§2+§esup§ oscillations were inhibited by zinc treatment, but phospho-phospholipase Cγ1 (p-PLCγ1), the upstream signaling molecule of Ca§ssup§2+§ esup§ oscillations, was unaffected. Moreover, a constitutively active form of Nfatc1 obviously rescued suppression of osteoclastogenesis by zinc. Conclusions: Taken together, these results demonstrate for the first time that the inhibitory effect of zinc during osteoclastogesis is caused by suppressing the Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. Thus, zinc may be a useful therapeutic candidate for the prevention of bone loss caused by NFATc1 activation in osteoclasts.

Original languageEnglish
Article number74
JournalCell Communication and Signaling
Volume11
Issue number1
DOIs
Publication statusPublished - 2013 Oct 4

Fingerprint

Calcineurin
Osteoclasts
Zinc
NFATC Transcription Factors
Osteogenesis
Bone
Trace Elements
Cytosol
Monocytes
Bone Marrow
Chemical activation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Park, Kwang Hwan ; Park, Boryung ; Yoon, Dong Suk ; Kwon, Seung Hyun ; Shin, Dong Min ; Lee, Jin Woo ; Lee, Hyun Gyu ; Shim, Jae Hyuck ; Park, Jeon Han ; Lee, Jae Myun. / Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. In: Cell Communication and Signaling. 2013 ; Vol. 11, No. 1.
@article{2d6ceb86234649e983f75a2c37707109,
title = "Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway",
abstract = "Background: Zinc, an essential trace element, inhibits osteoclast differentiation in vitro and in vivo. The molecular mechanism for the inhibitory effect of zinc, however, is poorly understood. The purpose of this study was to investigate the effect of zinc and determine its molecular mechanism on receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis in mouse bone marrow-derived monocyte cells (BMMs) and RAW264.7 cells. Results: In BMMs, zinc treatment during osteoclast differentiation decreased RANKL-induced osteoclast formation in a dose-dependent manner. We show that zinc suppressed the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Zinc also accumulated phospho-Nfatc1 (p-Nfatc1) in the cytosol in a dose-dependent manner and inhibited the translocation of Nfatc1 to the nucleus in RAW264.7 cells. Zinc suppressed the activities of Nfatc1 in the nucleus without changing the activities of NF-κB in RAW264.7 cells. In contrast, calcineurin activity decreased in response to zinc but its protein level was unchanged. RANKL-induced Ca§ssup§2+§esup§ oscillations were inhibited by zinc treatment, but phospho-phospholipase Cγ1 (p-PLCγ1), the upstream signaling molecule of Ca§ssup§2+§ esup§ oscillations, was unaffected. Moreover, a constitutively active form of Nfatc1 obviously rescued suppression of osteoclastogenesis by zinc. Conclusions: Taken together, these results demonstrate for the first time that the inhibitory effect of zinc during osteoclastogesis is caused by suppressing the Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. Thus, zinc may be a useful therapeutic candidate for the prevention of bone loss caused by NFATc1 activation in osteoclasts.",
author = "Park, {Kwang Hwan} and Boryung Park and Yoon, {Dong Suk} and Kwon, {Seung Hyun} and Shin, {Dong Min} and Lee, {Jin Woo} and Lee, {Hyun Gyu} and Shim, {Jae Hyuck} and Park, {Jeon Han} and Lee, {Jae Myun}",
year = "2013",
month = "10",
day = "4",
doi = "10.1186/1478-811X-11-74",
language = "English",
volume = "11",
journal = "Cell Communication and Signaling",
issn = "1478-811X",
publisher = "Signal Transduction Society",
number = "1",

}

Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. / Park, Kwang Hwan; Park, Boryung; Yoon, Dong Suk; Kwon, Seung Hyun; Shin, Dong Min; Lee, Jin Woo; Lee, Hyun Gyu; Shim, Jae Hyuck; Park, Jeon Han; Lee, Jae Myun.

In: Cell Communication and Signaling, Vol. 11, No. 1, 74, 04.10.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Zinc inhibits osteoclast differentiation by suppression of Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway

AU - Park, Kwang Hwan

AU - Park, Boryung

AU - Yoon, Dong Suk

AU - Kwon, Seung Hyun

AU - Shin, Dong Min

AU - Lee, Jin Woo

AU - Lee, Hyun Gyu

AU - Shim, Jae Hyuck

AU - Park, Jeon Han

AU - Lee, Jae Myun

PY - 2013/10/4

Y1 - 2013/10/4

N2 - Background: Zinc, an essential trace element, inhibits osteoclast differentiation in vitro and in vivo. The molecular mechanism for the inhibitory effect of zinc, however, is poorly understood. The purpose of this study was to investigate the effect of zinc and determine its molecular mechanism on receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis in mouse bone marrow-derived monocyte cells (BMMs) and RAW264.7 cells. Results: In BMMs, zinc treatment during osteoclast differentiation decreased RANKL-induced osteoclast formation in a dose-dependent manner. We show that zinc suppressed the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Zinc also accumulated phospho-Nfatc1 (p-Nfatc1) in the cytosol in a dose-dependent manner and inhibited the translocation of Nfatc1 to the nucleus in RAW264.7 cells. Zinc suppressed the activities of Nfatc1 in the nucleus without changing the activities of NF-κB in RAW264.7 cells. In contrast, calcineurin activity decreased in response to zinc but its protein level was unchanged. RANKL-induced Ca§ssup§2+§esup§ oscillations were inhibited by zinc treatment, but phospho-phospholipase Cγ1 (p-PLCγ1), the upstream signaling molecule of Ca§ssup§2+§ esup§ oscillations, was unaffected. Moreover, a constitutively active form of Nfatc1 obviously rescued suppression of osteoclastogenesis by zinc. Conclusions: Taken together, these results demonstrate for the first time that the inhibitory effect of zinc during osteoclastogesis is caused by suppressing the Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. Thus, zinc may be a useful therapeutic candidate for the prevention of bone loss caused by NFATc1 activation in osteoclasts.

AB - Background: Zinc, an essential trace element, inhibits osteoclast differentiation in vitro and in vivo. The molecular mechanism for the inhibitory effect of zinc, however, is poorly understood. The purpose of this study was to investigate the effect of zinc and determine its molecular mechanism on receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis in mouse bone marrow-derived monocyte cells (BMMs) and RAW264.7 cells. Results: In BMMs, zinc treatment during osteoclast differentiation decreased RANKL-induced osteoclast formation in a dose-dependent manner. We show that zinc suppressed the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Zinc also accumulated phospho-Nfatc1 (p-Nfatc1) in the cytosol in a dose-dependent manner and inhibited the translocation of Nfatc1 to the nucleus in RAW264.7 cells. Zinc suppressed the activities of Nfatc1 in the nucleus without changing the activities of NF-κB in RAW264.7 cells. In contrast, calcineurin activity decreased in response to zinc but its protein level was unchanged. RANKL-induced Ca§ssup§2+§esup§ oscillations were inhibited by zinc treatment, but phospho-phospholipase Cγ1 (p-PLCγ1), the upstream signaling molecule of Ca§ssup§2+§ esup§ oscillations, was unaffected. Moreover, a constitutively active form of Nfatc1 obviously rescued suppression of osteoclastogenesis by zinc. Conclusions: Taken together, these results demonstrate for the first time that the inhibitory effect of zinc during osteoclastogesis is caused by suppressing the Ca§ssup§2+§esup§-Calcineurin-NFATc1 signaling pathway. Thus, zinc may be a useful therapeutic candidate for the prevention of bone loss caused by NFATc1 activation in osteoclasts.

UR - http://www.scopus.com/inward/record.url?scp=84884779402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884779402&partnerID=8YFLogxK

U2 - 10.1186/1478-811X-11-74

DO - 10.1186/1478-811X-11-74

M3 - Article

C2 - 24088289

AN - SCOPUS:84884779402

VL - 11

JO - Cell Communication and Signaling

JF - Cell Communication and Signaling

SN - 1478-811X

IS - 1

M1 - 74

ER -